ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

1 Unprofitable Stock for Long-Term Investors and 2 to Ignore

SRPT Cover Image

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Unprofitable companies face an uphill battle, but not all are created equal. Luckily for you, StockStory is here to separate the promising ones from the weak. Keeping that in mind, here is one unprofitable company investing heavily to secure market share and two that may never reach the Promised Land.

Two Stocks to Sell:

Repligen (RGEN)

Trailing 12-Month GAAP Operating Margin: -5%

With over 13 strategic acquisitions since 2012 to build its comprehensive bioprocessing portfolio, Repligen (NASDAQ: RGEN) develops and manufactures specialized technologies that improve the efficiency and flexibility of biological drug manufacturing processes.

Why Do We Steer Clear of RGEN?

  1. Customers postponed purchases of its products and services this cycle as its revenue declined by 7.5% annually over the last two years
  2. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
  3. Efficiency has decreased over the last five years as its adjusted operating margin fell by 14.8 percentage points

Repligen is trading at $131.68 per share, or 71.4x forward P/E. Check out our free in-depth research report to learn more about why RGEN doesn’t pass our bar.

WEBTOON (WBTN)

Trailing 12-Month GAAP Operating Margin: -10.5%

Pioneering a vertical-scrolling format optimized for mobile devices, WEBTOON Entertainment (NASDAQ: WBTN) operates a global platform where creators publish serialized web-comics and web-novels that users can read in bite-sized episodes.

Why Are We Cautious About WBTN?

  1. Number of monthly active users has disappointed over the past two years, indicating weak demand for its offerings
  2. Historically negative EPS raises concerns for risk-averse investors and makes its earnings potential harder to gauge
  3. Low free cash flow margin of -0.8% for the last three years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders

WEBTOON’s stock price of $8.82 implies a valuation ratio of 20.5x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including WBTN in your portfolio.

One Stock to Buy:

Sarepta Therapeutics (SRPT)

Trailing 12-Month GAAP Operating Margin: -5.2%

Pioneering treatments for a devastating childhood muscle-wasting disease that primarily affects boys, Sarepta Therapeutics (NASDAQ: SRPT) develops and commercializes RNA-targeted therapies and gene therapies for rare genetic disorders, primarily Duchenne muscular dystrophy.

Why Will SRPT Outperform?

  1. Annual revenue growth of 51.3% over the last two years was superb and indicates its market share increased during this cycle
  2. Earnings per share have massively outperformed its peers over the last five years, increasing by 38.8% annually
  3. Cash burn has become less severe over the last five years, showing the company is making some progress toward financial sustainability

At $40.01 per share, Sarepta Therapeutics trades at 3.9x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.

While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.10
+0.70 (0.28%)
AAPL  275.25
+5.82 (2.16%)
AMD  237.52
-6.46 (-2.65%)
BAC  53.63
+0.21 (0.39%)
GOOG  291.74
+1.15 (0.40%)
META  627.08
-4.68 (-0.74%)
MSFT  508.68
+2.68 (0.53%)
NVDA  193.16
-5.89 (-2.96%)
ORCL  236.15
-4.68 (-1.94%)
TSLA  439.62
-5.61 (-1.26%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.